Methods of applying proteins to surfaces to form arrays are well known. The immobilization may be covalent or noncovalent, via a linker moiety, or tethering to an immobilized moiety. These methods are well known in the field of solid phase synthesis and micro-arrays, for example as described in Beier et al., Nucleic Acids Res. 27:1970-1-977 (1999), and U.S. Pat. No. 6,101,946 to Martinsky. Examples include binding moieties for attaching proteinaceous molecules to a solid support include streptavidin or avidin/biotin linkages, carbamate linkages, ester linkages, amide, thiolester, (N)-functionalized thiourea, functionalized maleimide, amino, disulfide, amide, hydrazone linkages, and among others. Furthermore, a number of companies offer commercial services for preparing protein arrays, for example Arrayit Corporation (Sunnyvale, Calif.). Preferably, the source of the proteins is an extract of the allergen source, such as those available from GREER® Allergy Immunotherapy (Lenoir, N.C.). Preferably, the extract of the allergen source is standardized.
Aspects of the inventions described herein have been described on the website of ARRAYIT® Corporation (arrayit.com) and links thereon. All such disclosures were made by another who obtained the subject matter disclosed directly or indirectly from the inventor of the present application.
1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov
1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018 arrayit.com/Products/products.html
Arrayit sales and marketing team receives $1,050,000 genomics and proteomics pre-solicitation announcement from top government agency National Institutes of Health NIH headquartered in Bethesda Maryland USA and operating with a $31.3 billion annual budget https://www.nih.gov
Arrayit government contracts team reports $440,000 sample testing solicitation from the world leader Department of Health and Human Services National Cancer Institute NCI headquartered in Bethesda Maryland USA and supported by a $5.4 billion annual budget (link: https://www.cancer.gov) cancer.gov
$ARYC market sub-brand Allergenex:
Spiriplex & Encore Holdings recently established partnership. Encore currently has around 200 hospital partnerships and averages around 2-3 a month.
A recent training video was just released last weekend.
Spiriplex specializes in micro-sample allergenic diagnostics, providing clinical laboratory services throughout the United States. We are a leading innovator in dried blood spot (DBS) technology which allows us to do a comprehensive allergy panel from just a few drops of blood taken from a finger stick.
I emailed healthcare connections and these are the next steps the company needs to take from this recent enrollment in order to participate in an upcoming healthcare event:
If you already went to the event page of the particular health fair and applied to the interested list, then check your dashboard overview section for the three main sections in the middle of the page -
If the event is in Pending, that means you applied and the host has not made a decision yet (each host picks the vendors they want off their interested list).
If the event is in Outstanding Registrations, that means you were selected and you need to officially secure your table by completing the last step.
Now are you talking the first razor you ever saw from Gillette? Realizing that it was an excellent product and the stock price was incredibly undervalued? Because I would’ve bought stock after buying a razor at that time. Or you mean last week after switching from another razor?
Market Data 
Markets 
